John-Paul Andersen

John-Paul Andersen Ph.D. is currently serving as the Chief Science Officer and Formulation Scientist at Phi since June 2021, having previously held the position of Chief Science Officer at Fractal Science until November 2022. Prior to these roles, John-Paul completed a Doctoral Fellowship in Biomedical Sciences at UT Health San Antonio, where a Ph.D. in Physiology and Pharmacology was earned. Earlier experience includes working as a Molecular Biologist and Genetic Sequence Analyst at Myriad Genetics from September 2013 to July 2015, as well as serving as an Environmental and Product Microbiologist and Japanese Distributor Relations and Support Specialist at Neways from March 2007 to April 2011. Academic qualifications include a Bachelor of Science in Biotechnology from Utah Valley University.